Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro
about
(Alkylamino) piperidine bis(heteroaryl)piperizine analogs are potent, broad-spectrum nonnucleoside reverse transcriptase inhibitors of drug-resistant isolates of human immunodeficiency virus type 1 (HIV-1) and select for drug-resistant variants of HAntiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitorEvaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replicationIn vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolatesPotency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors.Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcriptionEffect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patientsAntiviral therapy for human immunodeficiency virus infectionsNon-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3'-azido-3'-deoxythymidine (AZT)-resistant polymerase to AZT-5'-triphosphate.What can be Expected from Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in the Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) Infections?
P2860
Q28378859-861DC9B5-E0EC-4019-A732-5AE7ADE5DF28Q28378892-0BC6F4E1-143D-4840-A4C1-D108C54395A3Q28378991-4ABAAAC7-6DA1-4E82-B887-730FAB4CA6DAQ28379223-22A83996-62AF-4CBB-8900-734CA03D5C2CQ34108631-4E635C1D-5754-4449-BA96-BC2379EED24CQ35122784-E5EC1DD3-4DA0-4640-8533-ED003CB79652Q35137986-16B5931C-8079-4F4E-B70D-3CCFBDF847F3Q35366050-6E4289B8-C6CE-45C8-9A19-FDAFFCAD9068Q44548859-F2B2BE7F-B283-40A0-81D8-CC67A965D845Q45748524-25D13383-2940-4B2E-9920-0195547CA894
P2860
Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Bisheteroarylpiperazine revers ...... us type 1 replication in vitro
@ast
Bisheteroarylpiperazine revers ...... us type 1 replication in vitro
@en
Bisheteroarylpiperazine revers ...... us type 1 replication in vitro
@nl
type
label
Bisheteroarylpiperazine revers ...... us type 1 replication in vitro
@ast
Bisheteroarylpiperazine revers ...... us type 1 replication in vitro
@en
Bisheteroarylpiperazine revers ...... us type 1 replication in vitro
@nl
prefLabel
Bisheteroarylpiperazine revers ...... us type 1 replication in vitro
@ast
Bisheteroarylpiperazine revers ...... us type 1 replication in vitro
@en
Bisheteroarylpiperazine revers ...... us type 1 replication in vitro
@nl
P2093
P2860
P356
P1476
Bisheteroarylpiperazine revers ...... us type 1 replication in vitro
@en
P2093
P J Pagano
R R Hinshaw
P2860
P304
P356
10.1128/AAC.38.2.288
P407
P577
1994-02-01T00:00:00Z